PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 20, 2023Epilepsy & Behavior8 citationsOpen Access

Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

MFMercè FalipFLFrancisco Javier López‐GonzálezIMIsabel Martín‐Herranz

Key Points

Key points are not available for this paper at this time.

Abstract

Based on reflective MCDA methodology and stakeholders' experience in clinical management of epilepsy in Spain, cenobamate is perceived as a value-added option for the treatment of patients with DRE when compared with third-generation ASMs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Falip et al. (2023) studied this question.

synapsesocial.com/papers/69df3ebd35659245ec6144f7https://doi.org/10.1016/j.yebeh.2023.109350
Ask AI
Helpful
Bookmark
Share
View Full Paper